Professional
Added to YB: 2026-01-16
Pitch date: 2025-12-31
DHR [neutral]
Danaher Corporation
+4.84%
current return
Author Info
No bio for this author
Company Info
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.
Market Cap
$168.1B
Pitch Price
$228.81
Price Target
N/A
Dividend
0.54%
EV/EBITDA
23.24
P/E
48.89
EV/Sales
7.61
Sector
Life Sciences Tools and Services
Category
growth
Mar Vista U.S. Quality Strategy Portfolio Holding: Danaher Corporation
DHR (holding update): Stock rebounded Q4 2025 as bioprocessing, life sciences, diagnostics recovered from cyclical trough. Mgmt guides conservative 2026: 3-6% revenue growth (below LT trends) improving throughout year, high single digit EPS growth from op leverage. Strong balance sheet enables accretive capital deployment.
Read full article (1 min)